These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 7585011)

  • 1. Arresting amyloidosis in vivo using small-molecule anionic sulphonates or sulphates: implications for Alzheimer's disease.
    Kisilevsky R; Lemieux LJ; Fraser PE; Kong X; Hultin PG; Szarek WA
    Nat Med; 1995 Feb; 1(2):143-8. PubMed ID: 7585011
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of poly(vinylsulfonate) on murine AA amyloid: a high-resolution ultrastructural study.
    Inoue S; Hultin PG; Szarek WA; Kisilevsky R
    Lab Invest; 1996 Jun; 74(6):1081-90. PubMed ID: 8667612
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of amyloidosis using low-molecular-weight heparins.
    Zhu H; Yu J; Kindy MS
    Mol Med; 2001 Aug; 7(8):517-22. PubMed ID: 11591887
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Induction of perlecan gene expression precedes amyloid formation during experimental murine AA amyloidogenesis.
    Ailles L; Kisilevsky R; Young ID
    Lab Invest; 1993 Oct; 69(4):443-8. PubMed ID: 8231112
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of proteoglycans associated with mouse splenic AA amyloidosis.
    Stenstad T; Magnus JH; Husby G
    Biochem J; 1994 Oct; 303 ( Pt 2)(Pt 2):663-70. PubMed ID: 7980430
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel glycosaminoglycan precursors as anti-amyloid agents part II.
    Kisilevsky R; Szarek WA
    J Mol Neurosci; 2002; 19(1-2):45-50. PubMed ID: 12212792
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Brefeldin A inhibits experimentally induced AA amyloidosis.
    Stenstad T; Husby G
    J Rheumatol; 1996 Jan; 23(1):93-100. PubMed ID: 8838515
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of amyloid A amyloidogenesis in vivo and in tissue culture by 4-deoxy analogues of peracetylated 2-acetamido-2-deoxy-alpha- and beta-d-glucose: implications for the treatment of various amyloidoses.
    Kisilevsky R; Szarek WA; Ancsin JB; Elimova E; Marone S; Bhat S; Berkin A
    Am J Pathol; 2004 Jun; 164(6):2127-37. PubMed ID: 15161647
    [TBL] [Abstract][Full Text] [Related]  

  • 9. AA glomerular amyloid. An ultrastructural immunogold study of the colocalization of heparan sulphate proteoglycan and P component with amyloid fibrils together with changes in distribution of type IV collagen and fibronectin.
    Moss J; Shore I; Woodrow D
    Histopathology; 1994 May; 24(5):427-35. PubMed ID: 8088714
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Amyloidogenesis recapitulated in cell culture: a peptide inhibitor provides direct evidence for the role of heparan sulfate and suggests a new treatment strategy.
    Elimova E; Kisilevsky R; Szarek WA; Ancsin JB
    FASEB J; 2004 Nov; 18(14):1749-51. PubMed ID: 15345688
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Co-deposition of basement membrane components during the induction of murine splenic AA amyloid.
    Lyon AW; Narindrasorasak S; Young ID; Anastassiades T; Couchman JR; McCarthy KJ; Kisilevsky R
    Lab Invest; 1991 Jun; 64(6):785-90. PubMed ID: 2046330
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A high resolution ultrastructural study of experimental murine AA amyloid.
    Inoue S; Kisilevsky R
    Lab Invest; 1996 Mar; 74(3):670-83. PubMed ID: 8600318
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Perlecan binds to the beta-amyloid proteins (A beta) of Alzheimer's disease, accelerates A beta fibril formation, and maintains A beta fibril stability.
    Castillo GM; Ngo C; Cummings J; Wight TN; Snow AD
    J Neurochem; 1997 Dec; 69(6):2452-65. PubMed ID: 9375678
    [TBL] [Abstract][Full Text] [Related]  

  • 14. FK506 inhibits murine AA amyloidosis: possible involvement of T cells in amyloidogenesis.
    Ueda M; Ando Y; Nakamura M; Yamashita T; Himeno S; Kim J; Sun X; Saito S; Tateishi T; Bergström J; Uchino M
    J Rheumatol; 2006 Nov; 33(11):2260-70. PubMed ID: 16981291
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Heparan sulphate proteoglycans in Alzheimer's disease and amyloid-related disorders.
    van Horssen J; Wesseling P; van den Heuvel LP; de Waal RM; Verbeek MM
    Lancet Neurol; 2003 Aug; 2(8):482-92. PubMed ID: 12878436
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-amyloid drugs: potential in the treatment of diseases associated with aging.
    Kisilevsky R
    Drugs Aging; 1996 Feb; 8(2):75-83. PubMed ID: 8845588
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunohistochemical detection of haem oxygenase in AA amyloidogenesis.
    Kuroiwa M; Aoki K; Izumiyama N
    J Electron Microsc (Tokyo); 2004; 53(4):417-22. PubMed ID: 15582941
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A temporal and ultrastructural relationship between heparan sulfate proteoglycans and AA amyloid in experimental amyloidosis.
    Snow AD; Bramson R; Mar H; Wight TN; Kisilevsky R
    J Histochem Cytochem; 1991 Oct; 39(10):1321-30. PubMed ID: 1940305
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential binding of vascular cell-derived proteoglycans (perlecan, biglycan, decorin, and versican) to the beta-amyloid protein of Alzheimer's disease.
    Snow AD; Kinsella MG; Parks E; Sekiguchi RT; Miller JD; Kimata K; Wight TN
    Arch Biochem Biophys; 1995 Jun; 320(1):84-95. PubMed ID: 7793988
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of splenic glycosaminoglycans accumulated in vivo in experimentally induced amyloid-susceptible and amyloid-resistant mice.
    Sugumaran G; Elliott-Bryant R; Phung N; Vitseva O; Kuberan B; Lech M
    Scand J Immunol; 2004 Dec; 60(6):574-83. PubMed ID: 15584968
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.